Wu Haohao, Lan Pin, Zhou Kechun, Wu Xingzhen, Xie Lutao
Department of Emergency, Lishui Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China.
Front Med (Lausanne). 2025 Mar 17;12:1568410. doi: 10.3389/fmed.2025.1568410. eCollection 2025.
Mediastinal and cervical subcutaneous emphysema caused by anaerobic infections is rare in clinical practice, particularly when accompanied by sepsis, septic shock, and severe acute respiratory distress syndrome (ARDS). These cases pose significant treatment challenges. Veno-venous extracorporeal membrane oxygenation (VV-ECMO), as a life-saving intervention, has been increasingly utilized in patients with severe infections and refractory hypoxemia. This report aims to evaluate the effectiveness of VV-ECMO in the treatment of mediastinal and subcutaneous emphysema, sepsis, and severe ARDS caused by anaerobic infections, and to summarize relevant therapeutic strategies.
A 49-year-old male was admitted with fever, sore throat, chest tightness, and hoarseness. On admission, he presented with severe hypoxemia, sepsis, and acute kidney injury. Chest computed tomography (CT) revealed bilateral mediastinal emphysema and cervical subcutaneous emphysema. Next-generation sequencing (NGS) confirmed an anaerobic bacterial infection. Despite high-flow oxygen therapy and antibiotic treatment, the patient's oxygenation continued to deteriorate, culminating in cardiopulmonary arrest. VV-ECMO was initiated to improve oxygenation, alongside prone positioning ventilation, sputum clearance, and alveolar lavage. After 7 days of ECMO support and anti-infective treatment, the patient's oxygenation improved significantly, inflammatory markers decreased, and ECMO was successfully weaned.
VV-ECMO is of critical value in managing septic shock and ARDS caused by severe anaerobic infections, effectively improving oxygenation and supporting organ function. This case highlights the pivotal role of airway management, VV-ECMO support, and comprehensive therapeutic strategies in the management of complex infectious ARDS, providing valuable insights for similar clinical scenarios.
临床实践中,由厌氧菌感染引起的纵隔和颈部皮下气肿较为罕见,尤其是伴有脓毒症、感染性休克和严重急性呼吸窘迫综合征(ARDS)时。这些病例带来了重大的治疗挑战。静脉-静脉体外膜肺氧合(VV-ECMO)作为一种挽救生命的干预措施,已越来越多地应用于重症感染和难治性低氧血症患者。本报告旨在评估VV-ECMO在治疗由厌氧菌感染引起的纵隔和皮下气肿、脓毒症及严重ARDS中的有效性,并总结相关治疗策略。
一名49岁男性因发热、咽痛、胸闷和声音嘶哑入院。入院时,他表现为严重低氧血症、脓毒症和急性肾损伤。胸部计算机断层扫描(CT)显示双侧纵隔气肿和颈部皮下气肿。二代测序(NGS)证实为厌氧菌感染。尽管进行了高流量氧疗和抗生素治疗,患者的氧合仍持续恶化,最终导致心肺骤停。启动VV-ECMO以改善氧合,同时采用俯卧位通气、痰液清除和肺泡灌洗。经过7天的ECMO支持和抗感染治疗,患者的氧合显著改善,炎症指标下降,ECMO成功撤机。
VV-ECMO在治疗由严重厌氧菌感染引起的感染性休克和ARDS中具有关键价值,能有效改善氧合并支持器官功能。本病例突出了气道管理、VV-ECMO支持和综合治疗策略在复杂感染性ARDS管理中的关键作用,为类似临床情况提供了有价值的见解。